Loading JHS price...
Peers are the listed companies in the exchange's own industry group: Personal Care. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 11 Aug 2026), sales was Rs 30.4 cr and profit was Rs 1.1 cr.
- Reported a loss in FY22 and FY23 and FY24.
- Profit before interest covered interest -5.5 times in FY24 (Rs 1 cr of interest).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 18 results, the share rose on 10 and fell on 8, and moved by 3% or more on 10.
Q1 FY27: results filed 11 Aug 2026. The share went from its close on 10 Aug 2026 to its close on 12 Aug 2026 +11.36%.
Of every Rs 100 of sales in FY24, Rs 102 went on running costs, Rs 9.2 on depreciation, Rs 0.8 on interest and Rs 0.8 on tax; the year ended in a loss.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
| Measure | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | 11.5% | -23.2% | - |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | -0.8% | -8.9% | -2.4% | - |
| Net marginProfit after everything, per Rs 100 of sales. | -5.0% | -17.5% | -6.1% | - |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | -9.3% | -2.6% | - |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | - | -10.5% | -1.7% | -0.8% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | - | 0.00x | 0.02x | 0.08x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | 1.1x | -13.5x | -5.5x | - |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 215 Cr of assets. Its owners funded 81% of that and borrowings 7%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -3 Cr, spent Rs 13 Cr on plant and equipment, and cash fell by Rs 3 Cr over the year.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| GODREJCP Godrej Consumer Products Limited | 85,248 cr | 44.5x | 6.7x | 15.1% | 21.4% | 0.33 | 11.9% | +15.4% | 2.40% |
| DABUR Dabur India Limited | 63,740 cr | 32.4x | 5.6x | 16.5% | 21.0% | 0.09 | 14.4% | +10.6% | 2.23% |
| COLPAL Colgate Palmolive (India) Limited | 43,942 cr | 32.3x | 27.2x | 84.2% | - | 0.00 | 21.3% | +12.3% | 3.16% |
| CUPID Cupid Limited | 42,229 cr | 116.8x | 93.7x | 30.5% | 30.9% | 0.11 | 30.4% | +158.7% | 0.00% |
| GILLETTE Gillette India Limited | 23,649 cr | 35.4x | 25.0x | 70.6% | 84.6% | 0.00 | 21.0% | +10.8% | 3.13% |
| PGHH Procter & Gamble Hygiene and Health Care Limited | 22,109 cr | 28.0x | 29.3x | 104.9% | 135.4% | 0.00 | 18.6% | -4.9% | 3.82% |
| EMAMILTD Emami Limited | 15,989 cr | 21.4x | 5.5x | 25.7% | 28.7% | 0.04 | 19.2% | +14.9% | 3.28% |
| HONASA Honasa Consumer Limited | 14,427 cr | 58.2x | 10.2x | 17.7% | 17.8% | 0.00 | 9.8% | +27.0% | 0.00% |
| BAJAJCON Bajaj Consumer Care Limited | 5,059 cr | 23.2x | 6.7x | 29.5% | 30.2% | 0.00 | 18.0% | +28.1% | 0.00% |
| JHS JHS Svendgaard Laboratories Limited | 72 cr | - | 0.4x | -1.1% | -0.8% | 0.08 | -1.7% | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from -0.8% to -2.4% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | BHIM SAIN BASSI | SELL | 5,05,128 | 12.74 | Rs 0.64 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.